A Memorable Case Report

Fibrodysplasia ossificans progressiva 

 

 

T. Sathish Kumar, MD, DCH

Anna Simon, MD

Department of Child Health

Christian Medical College, Vellore India

 

 

 

Contact:

Anna Simon, MD

Associate Professor,

Department of Child Health,

Christian Medical College,

Vellore 632 004

Telephone No. 0416-2283350

Email: child1@cmcvellore.ac.in

 

Key words: fibrodysplasia ossificans progressiva, myositis ossificans.

 

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disease. It is characterized by widespread soft tissue ossification and congenital anomalies of the extremities. We report a 6 year old boy who was diagnosed as FOP on the basis of heterotopic calcification and hallux valgus.

 

Introduction

Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder of connective tissue characterized by congenital malformation of the great toes and by progressive post-natal heterotopic ossification of soft tissue.  We report a 6 year old boy who was diagnosed as FOP on basis of heterotopic calcification and deformities of great toes.

 

Case Report

A 6-year-old male child presented with a bony swelling over scapula and back of  the neck with restrictions of movement of neck towards right side for the past 6 months.  At 2 years of age he had empyema on right side for which thoracotomy and drainage was done. He was the first child born to non-consanguineous parents by cesearean section. His development was normal.  On examination, his weight was 20 kgs, height was 119 cms and head cirumference was 53 cms. He had torticollis towards right side. He had bony swelling over the right scapula over the thorocotomy scar and also on back side of neck (Fig.1a). He had restriction of movements of right shoulder. His thumb was stiff and hallux valgus deformity was seen in both the great toes (Fig 1b). His systemic examination did not reveal any other abnormality. Laboratory investigations revealed  serum calcium of 9.5 mg%, phosphorus  5.3 mg% and alkaline phosphate 513 IU/L.

 

Fig 1a. 6 year old male child having a bony swelling over the scapula and back side of neck. Note the  torticollis towards right side.

Fig 1b. Hallux valgus deformity of great toes

 

 

His skeletal radiographs revealed ectopic calcification over the right scapula. The calcification extended into the posterior facial planes of the neck (Fig.2).

 

Fig 2. Skeletal radiograph showing ectopic calcification over the right scapula. The calcification extending into the posterior facial planes of neck

 

 

He was diagnosed to have FOP on the basis of typical radiological features and hallux valgus. He was advised to take steroids during acute flare-ups followed by non-steroidal anti-inflammatory drugs. Intravenous pamidronate was recommended every 3 months to prevent further progression.

 

Discussion:

Gay Patin in 1962 described the first case of FOP as a woman who “turned into a log of wood”. [1] FOP is a disease of the mesodermal tissue, characterized by initial inflammation followed by subsequent proliferation of the fibrous tissue and formation of ectopic bone tissue. Its incidence is one case per two million. It is a disorder which generally occurs in the first three decades of life, and a majority of patients have onset of symptoms by the age of four years, but there can be a delay of many months before the diagnosis is made. [2] The disease predominantly affects boys. It is transmitted as a dominant trait.

 The ectopic bone tissue formed is located in soft parts, mainly in the connective tissue of the striated musculature. The lesions begin in the paravertebral musculature and progress into the scapula, proximal portion of the arms, pelvis, jaw and skull. [3] The ossification process can intensify in the presence of trauma, as occurred in our case. Exacerbation of FOP may occur spontaneously or be precipitated by trauma, such as intramuscular injections including vaccines [4], local anesthesia, muscle biopsy and careless venipuncture. Biopsy of calcified nodules is to be avoided if the diagnosis of FOP is clear on clinical and radiological grounds. Biopsy may result in recurrent ossification of the site, sometimes worse than the original lesion.  Symmetrical congenital malformations of the hands and feet occur in up to 90% of the cases and are considered essential for its diagnosis. [5] The most frequent congenital abnormalities are hypoplasia of the thumbs, big toes and hallux valgus. These are due to shortening of the first phalanges, as observed in our child.

There are no specific laboratory alterations in FOP. Skeletal radiography is the preferential examination for its diagnosis and follow-up, by depicting the appearance of new ossification. Bone scintigraphy with 99mTc-MDP may demonstrate early the heterotopic ossification and aid in the assessment of the extent and progression of the disease. [6]  The phenotype and natural history of FOP are by now so well defined that differential diagnosis is limited. Other disorders of ectopic ossification may be considered, such as Albright hereditary osteodystrophy, pseudomalignant heterotopic ossification, progressive osseous heteroplasia and even osteosarcoma. [7]  

To date, there is no effective therapy to impede progression of the disease. However, several drugs have been suggested for the treatment of FOP such as retinoic acid [8], warfarin, and diphosphonates. [9] Corticosteroids can be useful for the acute process, but they do not prevent ectopic calcification. Some authors have demonstrated that the use of oral or intravenous diphosphonate appears to be a therapeutic alternative to reduce ectopic calcifications. [10]

 

References

1. Lutwak L. Myositis ossificans progressiva. Mineral, metabolic and radioactive calcium studies of the effects of hormones. Am J Med. 1964;37:269-93.

2. Connor JM, Evans OA. Genetic aspects of fibrodysplasia  ossificans progressiva. J Med Genet. 1982;19:35-39.

3. Resnick D, Niwayama G. Soft tissues. In: Resnick D, editor. Diagnosis of Bone and joints disorders. 3rd Ed. Philadelphia; W.B. Saunders Company 1995. p. 4588- 4593.

4. Lanchoney TF, Cohen RB, Rocke DM, Zasloff MA, Kaplan FS.  Permanent heterotopic ossification at the injection site after diphtheria-tetanus-pertussis immunizations in children who

   have fibrodysplasia ossificans progressiva. J Pediatr. 1995;126:762-764.

5. Schroeder HW, Zasloff MA. The hand and foot malformations in fibrodysplasia ossificans progressiva. Johns Hopkins Med J. 1980;147:73-78.

6. Gülaldi NCM, Elahi N, Sasani J, Erbengi G.  Tc-99m MDP scanning in a patient with extensive fibrodysplasia ossificans progressiva. Clin Nucl Med. 1995;20:188-190.

7. Miller ES, Esterly NB, Fairley JA. Progressive osseous heteroplasia. Arch Dermatol. 1996;132:787-791.

8. Zasloff MA, Rocke OM, Crofford LJ, Hahn GV, Kaplan FS. Treatment of patients who have fibrodysplasia ossificans progressiva with isotretinoin. Clin Orthop Rel Res. 1998;346:121-129.

9. Rogers JG, Dorst JP, Geho WB. Use and complications of high dose disodium etidronate therapy in fibrodysplasia ossificans progressiva. J Pediatr. 1977;91:1011-1014.

10. Brantus JF, Meunier PJ. Effects of intravenous etidronate and oral corticosteroids in fibrodysplasia ossificans progressiva. Clin Orthop Rel Res. 1998;346:117-120.